Van Chanh Ngo

671 total citations
6 papers, 570 citations indexed

About

Van Chanh Ngo is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Hepatology. According to data from OpenAlex, Van Chanh Ngo has authored 6 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Hepatology. Recurrent topics in Van Chanh Ngo's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer Mechanisms and Therapy (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Van Chanh Ngo is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer Mechanisms and Therapy (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Van Chanh Ngo collaborates with scholars based in Singapore, Australia and Japan. Van Chanh Ngo's co-authors include Hung Huynh, Khee Chee Soo, Pierce K. H. Chow, Hock Soo Ong, Alexander Yaw Fui Chung, Choon Hua Thng, Heng Nung Koong, Su Pin Choo, Donald Poon and Evelyn Tran and has published in prestigious journals such as Clinical Cancer Research, Journal of Hepatology and Molecular Cancer Therapeutics.

In The Last Decade

Van Chanh Ngo

6 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Van Chanh Ngo Singapore	6	319	250	220	111	103	6	570
Sean Clark-Garvey United States	4	218 0.7×	289 1.2×	208 0.9×	176 1.6×	96 0.9×	12	569
Liangcai Wu China	15	277 0.9×	81 0.3×	80 0.4×	166 1.5×	200 1.9×	24	635
Tameyoshi Yamamoto Japan	11	253 0.8×	264 1.1×	107 0.5×	253 2.3×	199 1.9×	30	675
Lantian Tian China	11	301 0.9×	125 0.5×	56 0.3×	128 1.2×	218 2.1×	21	549
Wai Meng David Tai Singapore	12	220 0.7×	265 1.1×	127 0.6×	280 2.5×	96 0.9×	33	645
Diyu Huang China	9	169 0.5×	123 0.5×	59 0.3×	136 1.2×	96 0.9×	27	466
James Christensen United States	4	245 0.8×	203 0.8×	70 0.3×	137 1.2×	65 0.6×	8	453
Hamza Chettouh France	6	233 0.7×	110 0.4×	58 0.3×	82 0.7×	112 1.1×	7	421
James Huber United States	7	382 1.2×	125 0.5×	45 0.2×	159 1.4×	194 1.9×	10	564
Cheng-Chung Wu Taiwan	14	259 0.8×	155 0.6×	42 0.2×	146 1.3×	115 1.1×	18	641

Countries citing papers authored by Van Chanh Ngo

Since Specialization

Citations

This map shows the geographic impact of Van Chanh Ngo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Van Chanh Ngo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Van Chanh Ngo more than expected).

Fields of papers citing papers by Van Chanh Ngo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Van Chanh Ngo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Van Chanh Ngo. The network helps show where Van Chanh Ngo may publish in the future.

Co-authorship network of co-authors of Van Chanh Ngo

This figure shows the co-authorship network connecting the top 25 collaborators of Van Chanh Ngo. A scholar is included among the top collaborators of Van Chanh Ngo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Van Chanh Ngo. Van Chanh Ngo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Shu, Yang, Van Chanh Ngo, Wei Jie Ong, et al.. (2009). AZD6244 (ARRY-142886) enhances the therapeutic efficacy of sorafenib in mouse models of gastric cancer. Molecular Cancer Therapeutics. 8(9). 2537–2545. 28 indexed citations

2.

Huynh, Hung, Van Chanh Ngo, Heng Nung Koong, et al.. (2009). Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. 13(8b). 2673–2683. 108 indexed citations

3.

Huynh, Hung, Van Chanh Ngo, Heng Nung Koong, et al.. (2009). AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC). Journal of Hepatology. 52(1). 79–87. 85 indexed citations

4.

Huynh, Hung, Jonathan Lee, Pierce K. H. Chow, et al.. (2009). Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor. Molecular Cancer Therapeutics. 8(1). 152–159. 50 indexed citations

5.

Huynh, Hung, Pierce K. H. Chow, Khee Chee Soo, et al.. (2008). RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. 13(7). 1371–1380. 117 indexed citations

6.

Huynh, Hung, Van Chanh Ngo, Joseph Fargnoli, et al.. (2008). Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma. Clinical Cancer Research. 14(19). 6146–6153. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact